SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (9560)6/23/2006 2:59:59 AM
From: Robohogs  Respond to of 10280
 
I do not think an M&A deal is precluded here (as long as deal is held off until end of commercial terms - i.e., 180 days from termination notice) - based more on my thoughts on such deals than that heavily redacted language.

Jon



To: DewDiligence_on_SI who wrote (9560)6/25/2006 3:20:38 PM
From: John Metcalf  Respond to of 10280
 
Thanks, Dew, for digging out the non-compete language. As Jon noted, it is not conclusive due to redactions, particularly definitions. Section 14.1.(c) seems to allow a competing product, but prohibits negative ads.

But I don't have enough industry experience, legal knowledge, nor information to know whether Pfizer would be constrained in buying a product that is already on the market.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News